Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Gain Therapeutics (GANX) Return on Assets (2021 - 2025)

Gain Therapeutics has reported Return on Assets over the past 5 years, most recently at 1.86% for Q3 2025.

  • Quarterly results put Return on Assets at 1.86% for Q3 2025, down 59.0% from a year ago — trailing twelve months through Sep 2025 was 1.86% (down 59.0% YoY), and the annual figure for FY2024 was 1.33%, down 29.0%.
  • Return on Assets for Q3 2025 was 1.86% at Gain Therapeutics, down from 1.73% in the prior quarter.
  • Over the last five years, Return on Assets for GANX hit a ceiling of 0.01% in Q4 2022 and a floor of 1.86% in Q3 2025.
  • Median Return on Assets over the past 5 years was 0.3% (2023), compared with a mean of 0.76%.
  • Biggest five-year swings in Return on Assets: grew 18bps in 2022 and later crashed -135bps in 2023.
  • Gain Therapeutics' Return on Assets stood at 0.19% in 2021, then soared by 95bps to 0.01% in 2022, then tumbled by -14232bps to 1.36% in 2023, then dropped by -13bps to 1.54% in 2024, then decreased by -21bps to 1.86% in 2025.
  • The last three reported values for Return on Assets were 1.86% (Q3 2025), 1.73% (Q2 2025), and 1.76% (Q1 2025) per Business Quant data.